This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fleischmann, A. Articles by Studer, U. E. Search for Related Content PubMed PubMed Citation Articles by Fleischmann, A. Articles by Studer, U. E. Social Bookmarking                            What's this?

Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor

From the Departments of Pathology and Urology, University of Bern, Bern, Switzerland

Address reprint requests to Urs E. Studer, MD, Department of Urology, University of Bern, Inselspital, CH-3010 Bern, Switzerland; e-mail: urs.studer{at}insel.ch

PURPOSE: To analyze the prognostic impact of risk factors for urothelial carcinoma of the bladder (UCB) with pelvic lymph node (LN) metastases.

PATIENTS AND METHODS: We analyzed a consecutive series of 507 patients with UCB who were preoperatively staged N0M0. One hundred one of 124 eligible patients who were treated with radical cystectomy and standardized extended bilateral pelvic lymphadenectomy with curative intent and had postoperatively confirmed LN metastases were evaluated in regard to recurrence-free and overall survival.

RESULTS: A median of 22 nodes per patient (range, 10 to 43 nodes) were removed and examined. Median recurrence-free and overall survival durations were 17 months and 21 months (range for both, 1 to 191 months), respectively. In the multivariate analysis for recurrence-free survival, extracapsular extension of LN metastases was the strongest prognostic factor (P = .019). Other variables such as tumor stage (pT1/2 v pT3 and pT4), the number (< five v five), and the percentage (< 20% v 20%) of metastatic nodes had a significant influence on recurrence-free and overall survival in the univariate analysis. However, they all failed to be significant prognostic factors in the multivariate analysis.

CONCLUSION: The results of this study indicate that radical cystectomy with bilateral lymphadenectomy can have a curative effect in a subset of patients with pelvic LN positive UCB. Provided that a representative number of LNs are removed by meticulous lymphadenectomy and that a thorough histologic examination is performed, prognosis for such patients can be determined quite reliably. In the multivariate analysis, extracapsular extension of LN metastases was the strongest factor predicting prognosis.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Shirotake, E. Kikuchi, K. Matsumoto, S. Yazawa, T. Kosaka, A. Miyajima, K. Nakagawa, and M. Oya Role of Pelvic Lymph Node Dissection in Lymph Node-Negative Patients with Invasive Bladder Cancer Jpn. J. Clin. Oncol., November 3, 2009; (2009) hyp147v1. [Abstract] [Full Text] [PDF]

				R. Thurairaja, U. E. Studer, and F. C. Burkhard Indications, Extent, and Benefits of Pelvic Lymph Node Dissection for Patients with Bladder and Prostate Cancer Oncologist, January 1, 2009; 14(1): 40 - 51. [Abstract] [Full Text] [PDF]

				A. M. Bell, B. R. DeYoung, J. Weydert, Y.-C. Lee, C.-T. Wu, and Y.-L. Chang Extranodal Extension in Metastatic Non-small Cell Lung Cancer Chest, December 1, 2007; 132(6): 2058 - 2060. [Full Text] [PDF]

				S. M. Cohen, A. Goel, J. Phillips, R. D. Ennis, and M. L. Grossbard The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer Oncologist, June 1, 2006; 11(6): 630 - 640. [Abstract] [Full Text] [PDF]